Mankind Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE634S01028
NSEID: MANKIND
BSEID: 543904
View on NSE | View on BSE

INR

2,001.15

-4.7 (-0.23%)

BSENSE

Apr 01

BSE+NSE Vol: 9.8 lacs

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,001.15",
    "chg": -4.7,
    "chgp": "-0.23%",
    "dir": -1,
    "prev_price": "2,005.85",
    "mcapval": "82,978.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Apr 01",
    "curr_time": "",
    "bse_nse_vol": "9.8 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 01, 2026",
    "traded_date_str": "2026 04 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Gains 2.03%: 2 Key Factors Driving This Week’s Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-gains-203-2-key-factors-driving-this-weeks-move-3921297",
        "imagepath": "",
        "date": "2026-03-28 10:05:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock hits 52-week low at Rs.1,922.45 amid sector and market downturn</p>\n                    <p><strong>24 Mar:</strong> Strong rebound with 3.37% gain supported by market recovery</p>\n                    <p><strong>25 Mar:</strong> Continued upward momentum with 1.66% rise and surge in delivery volumes</p>\n                    <p><strong>27 Mar:</strong> Sharp open interest surge in derivatives amid bullish positioning, stock closes at Rs.2,040.25 (+0.99%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,922.45</div></div>\n            ..."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3920134",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_oi_spurts_by_underlying_3920134.png",
        "date": "2026-03-27 15:01:08",
        "description": "Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling heightened investor participation and potential shifts in market positioning. The stock outperformed its sector and broader indices, supported by increased volumes and a sustained upward price trend over recent sessions."
      },
      {
        "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Rising Investor Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-rising-investor-activity-3919898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_oi_spurts_by_underlying_3919898.png",
        "date": "2026-03-27 14:00:52",
        "description": "Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock outperformed its sector and broader indices, supported by rising volumes and a notable increase in delivery volumes, suggesting growing investor conviction despite a recent downgrade in its mojo rating."
      },
      {
        "title": "Why is Mankind Pharma Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-mankind-pharma-ltd-fallingrising-3908894",
        "imagepath": "",
        "date": "2026-03-24 01:36:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for several sessions, recording a consecutive three-day fall that has resulted in an 8.56% loss over this period. On the day in question, the share price hit a new 52-week low of ₹1,909.9, marking a 4.49% intraday decline. This underperformance is slightly worse than the Pharmaceuticals &amp; Drugs sector, which itself fell by 3.62%, indicating sector-wide weakness but with Mankind Pharma lagging marginally behind.</p>\n<p>Trading volumes have increased, with delivery volumes on 20 Mar rising by 83.22% compared to the five-day average, suggesting heightened investor activity. However, the weighted average price indicates that more shares were traded closer to the day’s low, signalling selling pressure. ..."
      },
      {
        "title": "Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-amid-market-downturn-3907445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3907445.png",
        "date": "2026-03-23 11:25:47",
        "description": "For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting sustained selling pressure amid broader sector weakness."
      },
      {
        "title": "Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-hits-52-week-low-amid-sector-and-market-downturn-3907446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3907446.png",
        "date": "2026-03-23 11:25:47",
        "description": "For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting intensified selling pressure amid broader sector weakness."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3905942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_mojoScore_3905942.png",
        "date": "2026-03-23 10:10:16",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Mankind Pharma Declines 6.45%: 4 Key Factors Behind the Weekly Slide",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-declines-645-4-key-factors-behind-the-weekly-slide-3905072",
        "imagepath": "",
        "date": "2026-03-21 11:02:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock opens at Rs.2,091.90, down 2.14%</p>\n                    <p><strong>19 Mar:</strong> New 52-week low of Rs.2,010.1 amid sharp decline</p>\n                    <p><strong>20 Mar:</strong> Further 52-week low at Rs.1,985.3 and technical downgrade</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.1,999.75, down 6.45% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,137.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,999.75</..."
      },
      {
        "title": "Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.1985.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-of-rs19853-3902565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MankindPharmaLt_priceRelatedfactors_3902565.png",
        "date": "2026-03-20 09:46:07",
        "description": "Mankind Pharma Ltd’s stock price declined to a fresh 52-week low of Rs.1985.3 today, marking a significant downturn amid ongoing challenges in performance and valuation pressures. The stock has underperformed its sector and benchmark indices, reflecting a cautious market stance towards the mid-cap pharmaceutical company."
      }
    ],
    "total": 495,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Intimation of closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "18-Mar-2026",
      "details": "Please find attached press release titled Mankind Pharma acquires Rivotril brand for India reinforcing focus on chronic CNS therapies.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "16-Mar-2026",
      "details": "Please find attached intimation regarding allotment of 23256 equity shares pursuant to Mankind Employee Stock Option Plan 2022.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Gains 2.03%: 2 Key Factors Driving This Week’s Move

2026-03-28 10:05:25

Key Events This Week

23 Mar: Stock hits 52-week low at Rs.1,922.45 amid sector and market downturn

24 Mar: Strong rebound with 3.37% gain supported by market recovery

25 Mar: Continued upward momentum with 1.66% rise and surge in delivery volumes

27 Mar: Sharp open interest surge in derivatives amid bullish positioning, stock closes at Rs.2,040.25 (+0.99%)

Week Open

Rs.1,922.45

...

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-03-27 15:01:08

Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling heightened investor participation and potential shifts in market positioning. The stock outperformed its sector and broader indices, supported by increased volumes and a sustained upward price trend over recent sessions.

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Rising Investor Activity

2026-03-27 14:00:52

Mankind Pharma Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock outperformed its sector and broader indices, supported by rising volumes and a notable increase in delivery volumes, suggesting growing investor conviction despite a recent downgrade in its mojo rating.

Read full news article

Why is Mankind Pharma Ltd falling/rising?

2026-03-24 01:36:00

Recent Price Movement and Market Context

The stock has been under pressure for several sessions, recording a consecutive three-day fall that has resulted in an 8.56% loss over this period. On the day in question, the share price hit a new 52-week low of ₹1,909.9, marking a 4.49% intraday decline. This underperformance is slightly worse than the Pharmaceuticals & Drugs sector, which itself fell by 3.62%, indicating sector-wide weakness but with Mankind Pharma lagging marginally behind.

Trading volumes have increased, with delivery volumes on 20 Mar rising by 83.22% compared to the five-day average, suggesting heightened investor activity. However, the weighted average price indicates that more shares were traded closer to the day’s low, signalling selling pressure. ...

Read full news article

Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens

2026-03-23 11:25:47

For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting sustained selling pressure amid broader sector weakness.

Read full news article

Mankind Pharma Ltd Falls to 52-Week Low of Rs 1929.55 as Sell-Off Deepens

2026-03-23 11:25:47

For the third consecutive session, Mankind Pharma Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 1929.55 on 23 Mar 2026. This marks a 7.73% drop over the last three days, reflecting intensified selling pressure amid broader sector weakness.

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-03-23 10:10:16

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Mankind Pharma Declines 6.45%: 4 Key Factors Behind the Weekly Slide

2026-03-21 11:02:08

Key Events This Week

16 Mar: Stock opens at Rs.2,091.90, down 2.14%

19 Mar: New 52-week low of Rs.2,010.1 amid sharp decline

20 Mar: Further 52-week low at Rs.1,985.3 and technical downgrade

20 Mar: Week closes at Rs.1,999.75, down 6.45% for the week

Week Open

Rs.2,137.65

Week Close

Rs.1,999.75Read full news article

Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.1985.3

2026-03-20 09:46:07

Mankind Pharma Ltd’s stock price declined to a fresh 52-week low of Rs.1985.3 today, marking a significant downturn amid ongoing challenges in performance and valuation pressures. The stock has underperformed its sector and benchmark indices, reflecting a cautious market stance towards the mid-cap pharmaceutical company.